During the last session, Eyenovia Inc (NASDAQ:EYEN)’s traded shares were 6.98 million, with the beta value of the company hitting 1.44. The 52-week high for the EYEN share is $2.57, that puts it down -2755.56 from that peak though still a striking 11.11% gain since the share price plummeted to a 52-week low of $0.08. The company’s market capitalization is $9.34M, and the average intraday trading volume over the past 10 days was 16.63 million shares, and the average trade volume was 7.00 million shares over the past three months.
Eyenovia Inc (NASDAQ:EYEN) trade information
Eyenovia Inc (EYEN) registered a -5.80% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.80% in intraday trading to $0.09, hitting a weekly high. The stock’s 5-day price performance is -9.49%, and it has moved by -82.64% in 30 days. Based on these gigs, the overall price performance for the year is -95.03%. The short interest in Eyenovia Inc (NASDAQ:EYEN) is 2.14 million shares and it means that shorts have 2.45 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Eyenovia Inc (EYEN) estimates and forecasts
Statistics show that Eyenovia Inc has underperformed its competitors in share price, compared to the industry in which it operates. Eyenovia Inc (EYEN) shares have gone down -85.90% during the last six months, with a year-to-date growth rate less than the industry average at 10.61% against 17.10. In the rating firms’ projections, revenue will increase 22,670.45% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 848.5k as predicted by 2 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 400k by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 2.59k and 4.99k respectively. In this case, analysts expect current quarter sales to grow by 32,660.62% and then jump by 7,916.03% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.26%. While earnings are projected to return 9.85% in 2024.
EYEN Dividends
Eyenovia Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Eyenovia Inc (NASDAQ:EYEN)’s Major holders
Eyenovia Inc insiders own 9.99% of total outstanding shares while institutional holders control 13.73%, with the float percentage being 15.25%. ARMISTICE CAPITAL, LLC is the largest shareholder of the company, while 67.0 institutions own stock in it. As of 2024-06-30, the company held over 6.06 million shares (or 13.0037% of all shares), a total value of $3.6 million in shares.
The next largest institutional holding, with 1.88 million shares, is of VANGUARD GROUP INC’s that is approximately 4.0365% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.12 million.
